查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲快速检测试剂盒市场预测至 2030 年 - 区域分析 - 按类型、产品、技术、应用和最终用户
市场调查报告书
商品编码
1562202

欧洲快速检测试剂盒市场预测至 2030 年 - 区域分析 - 按类型、产品、技术、应用和最终用户

Europe Rapid Test Kit Market Forecast to 2030 - Regional Analysis - by Type, Product, Technology, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 172 Pages | 订单完成后即时交付

价格

2022年欧洲快速检测试剂盒市值为52.4446亿美元，预计2030年将达到77.6357亿美元；预计2022年至2030年复合年增长率为5.0%。

製造商的策略性倡议推动欧洲快速检测试剂盒市场

快速检测试剂盒市场的製造商强调采用创新、产品发布和批准等策略来维持市场竞争优势。快速检测试剂盒市场企业的此类策略倡议有利于整个市场。

2022 年，亚洲女性和胎儿健康领域的先驱、总部位于新加坡的诊断製造商 INEX Innovate 的卵巢癌旗舰解决方案 OvaCis 快速检测获得了 CE 标誌。到 2022 年底，OvaCis 是一种首创的床边 (POCT) 测试，可在手术室环境中区分良性和恶性卵巢囊肿，预计将在欧盟和东南亚首次亮相市场。

2022 年 1 月，全球领先的即时护理和家庭诊断测试以及样本采集技术领域的 OraSure Technologies, Inc. 推出了 OraQuick HIV 自检，这是一种基于口腔拭子的 HIV 家庭测试。 ，面向欧洲市场。该测试可在六个欧洲国家进行：英国、法国、德国、义大利、西班牙和葡萄牙。

2021年，随着CE证书的颁发，FUJIFILM Europe GmbH被授权申请CE标誌，并推出用于诊断SARS-CoV-2感染的抗原检测试剂盒。富士胶片使用的技术称为专有银放大免疫色谱法，它基于用于放大待冲洗照片的相同技术。

2020 年 12 月，美国食品药物管理局 (FDA) 发布了虚拟引导 BinaxNOW COVID-19 Ag 卡（由 Abbott 生产）快速检测的紧急使用授权 (EUA)，适用于家庭使用来检测新冠病毒 - 19. BinaxNOW 是一种分布广泛且最实惠的快速测试之一，可在几分钟内提供结果。

2020 年 7 月，FDA 授予紧急使用授权 (EUA)，用于快速、护理点 SARS-CoV-2 诊断测试，与其广泛使用的 BD Veritor Plus 系统一起使用。新的检测方法可在易于使用、高度便携的仪器上 15 分钟内产生结果。该测试旨在透过提供即时结果并帮助患者在测试设施中时快速做出决策，从而改善对 COVID-19 诊断的获取。

欧洲快速检测试剂盒市场概况

德国的糖尿病盛行率正在显着增加。根据国际糖尿病联盟的数据，2021 年约有 6,200 万人患有糖尿病。此外，根据欧洲疾病预防控制中心的报告，2019年欧盟（EU）登记了8,641例疟疾病例，其中确诊8,638例（>99%）。 2022年9月，德国与联合国爱滋病规划署（UNAIDS）签署了价值13.4亿美元的协议，旨在对抗爱滋病、结核病和疟疾；由此，该国的捐款比 2019 年增加了 30%。控制和消除疟疾的资金总额为33亿美元，其中德国提供2亿美元。因此，随着糖尿病、爱滋病、结核病和疟疾等传染病等传染病率的上升，未来几年德国的快速检测试剂盒市场可能会成长。

欧洲快速检测试剂盒市场收入及 2030 年预测（百万美元）

欧洲快速检测试剂盒市场细分

欧洲快速检测试剂盒市场根据类型、产品、技术、应用、最终用户和国家进行细分。根据类型，欧洲快速检测试剂盒市场分为快速抗原检测、快速抗体检测等。 2022 年，快速抗原检测领域占据最大的市场。

从产品来看，欧洲快速检测试剂盒市场分为非处方快速检测试剂盒和专业快速检测试剂盒。非处方快速检测试剂盒细分市场在 2022 年占据更大的市场。

依技术划分，欧洲快速检测试剂盒市场分为侧流检测、固相检测、凝集检测、免疫斑点检测和基于细胞组成的检测。 2022 年，侧流分析领域占据最大的市场份额。

根据应用，欧洲快速检测试剂盒市场分为血糖检测、传染病检测、怀孕及生育、心臟代谢检测等。 2022年，血糖检测领域占据最大的市场份额。

就最终用户而言，欧洲快速检测试剂盒市场分为医院和诊所、家庭护理、诊断中心等。 2022 年，医院和诊所领域占据最大的市场。

根据国家/地区，欧洲快速检测试剂盒市场分为英国、德国、法国、义大利、西班牙和欧洲其他地区。 2022年，德国在欧洲快速检测试剂盒市场份额中占据主导地位。

F. Hoffmann-La Roche Ltd、Becton Dickinson and Co、ARKRAY Inc、Sysmex Partec GmbH、Fujirebio Europe NV、bioMerieux SA、Cepheid、Meril Life Sciences Pvt Ltd、QIAGEN NV、OraSure Technologies Inc、广州万孚生物科技有限公司、 Denka Co Ltd、Abbott Laboratories、Trinity Biotech Plc、Premier Medical Corp Pvt Ltd、Bio-Rad Laboratories Inc、Hologic Inc、DiaSorin SpA 和 Beckman Coulter Inc 是欧洲快速检测试剂盒市场的一些领先参与者。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲快速检测试剂盒市场 - 主要产业动态

  • 市场驱动因素
    • 遗传性疾病和传染病的盛行率不断上升
    • 製造商的策略倡议
  • 市场限制
    • 与结果准确性相关的不确定性
  • 市场机会
    • 对 PCR 技术的偏好不断增加
  • 未来趋势
    • 快速抗原检测的创新
  • 影响分析

第 5 章：快速测试套件市场 - 欧洲市场分析

  • 概述
  • 快速测试套件市场收入，2020 - 2030

第 6 章：欧洲快速检测试剂盒市场分析 - 按类型

  • 概述
  • 快速抗原检测
  • 快速抗体检测
  • 其他的

第 7 章：欧洲快速检测试剂盒市场分析 - 按产品

  • 概述
  • 非处方快速检测试剂盒
  • 专业快速检测试剂盒

第 8 章：欧洲快速检测试剂盒市场分析 - 按技术

  • 概述
  • 侧流层析
  • 固相
  • 凝集
  • 免疫斑点测定
  • 基于蜂窝组件

第 9 章：欧洲快速检测试剂盒市场分析 - 按应用

  • 概述
  • 血糖测试
  • 传染病检测
  • 心臟代谢测试
  • 怀孕和生育
  • 其他的

第 10 章：欧洲快速检测试剂盒市场分析 - 按最终用户

  • 概述
  • 医院和诊所
  • 诊断中心
  • 居家护理
  • 其他的

第 11 章：欧洲快速检测试剂盒市场 - 国家分析

  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区

第 12 章：产业格局

  • 概述
  • 快速检测试剂盒市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 13 章：公司简介

  • F. Hoffmann-La Roche Ltd
  • Becton Dickinson and Co
  • ARKRAY Inc
  • Sysmex Partec GmbH
  • Fujirebio Europe NV
  • bioMerieux SA
  • Cepheid
  • Meril Life Sciences Pvt Ltd
  • QIAGEN NV
  • OraSure Technologies Inc
  • Guangzhou Wondfo Biotech Co Ltd
  • Denka Co Ltd
  • Abbott Laboratories
  • Trinity Biotech Plc
  • Bio-Rad Laboratories Inc
  • Hologic Inc
  • DiaSorin SpA
  • Premier Medical Corp Pvt Ltd
  • Beckman Coulter Inc

第 14 章：附录

Product Code: BMIRE00030428

The Europe rapid test kit market was valued at US$ 5,244.46 million in 2022 and is expected to reach US$ 7,763.57 million by 2030; it is estimated to record a CAGR of 5.0% from 2022 to 2030.

Strategic Initiatives by Manufacturers Drive Europe Rapid Test Kit Market

Manufacturers in the rapid test kits market emphasize on the adoption of strategies such as innovations, and product launches and approvals to maintain a competitive edge in the market. Such strategic initiatives by companies in the rapid test kits market benefit the overall market.

In 2022, Singapore-based diagnostics manufacturer INEX Innovate, a pioneer in the women's and fetal health sector in Asia, has received a CE mark for OvaCis Rapid Test, its flagship solution for ovarian cancer. By the end of 2022, OvaCis-a first-of-its-kind point-of-care (POCT) test that distinguishes benign from malignant ovarian cysts in an operating room setting-is expected to make its debut in the EU and Southeast Asian markets.

In January 2022, OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing as well as sample collection technologies, launched the OraQuick HIV Self-Test, an oral swab-based in-home test for HIV-1 and HIV-2, for the European market. The test is accessible in six European countries: the UK, France, Germany, Italy, Spain, and Portugal.

In 2021, following the issuance of the CE certificate, FUJIFILM Europe GmbH was authorized to apply the CE mark and introduce an antigen test kit for the diagnosis of SARS-CoV-2 infection. The technique being utilized by Fujifilm is called proprietary silver amplification immunochromatography, and it is based on the same technology that is used to amplify the photos to be developed.

In December 2020, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for a virtually guided BinaxNOW COVID-19 Ag Card (by Abbott) rapid test, indicated for the at-home use for detection of COVID-19. BinaxNOW is a widely distributed and one of the most affordable rapid tests, which provides results in minutes.

In July 2020, the FDA granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor Plus System. The new assay generates results in 15 minutes on an easy-to-use, highly portable instrument. The test was meant to improve access to COVID-19 diagnostics by providing real-time results and aiding quick decision-making while the patient is still in the testing facility.

Europe Rapid Test Kit Market Overview

The prevalence of the diabetes in Germany has been increasing significantly. According to the International Diabetes Federation, in 2021 ~62 million people were having diabetes. Moreover, according to the European Center for Disease Prevention and Control report, 8,641 malarial cases were registered in the European Union (EU) in 2019, of which 8,638 (>99%) were confirmed diagnoses. In September 2022, Germany signed an agreement worth US$ 1.34 billion with The Joint United Nations Programme on HIV/AIDS (UNAIDS) aiming to fight AIDS, tuberculosis, and malaria; with this, the country raised its contribution by 30% compared to 2019. Further, as per the endmalaria.org 2020 report, international sources provided 69% of total funding aiming for malaria control and elimination. The total funding for malaria control and elimination accounted for US$ 3.3 billion, including US$ 0.2 billion contributed by Germany. Thus, the rapid test kits market is likely to grow in Germany in the coming years with the rising prevalence of infectious disease such as diabetes, AIDS, tuberculosis, and malaria.

Europe Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)

Europe Rapid Test Kit Market Segmentation

The Europe rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the Europe rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.

In terms of product, the Europe rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.

By technology, the Europe rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.

Based on application, the Europe rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.

In terms of end user, the Europe rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.

Based on country, the Europe rapid test kit market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe rapid test kit market share in 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Sysmex Partec GmbH, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the Europe rapid test kit market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Rapid Test Kits Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.1.2 Strategic Initiatives by Manufacturers
  • 4.2 Market Restraints
    • 4.2.1 Uncertainties Related to Accuracy of Results
  • 4.3 Market Opportunities
    • 4.3.1 Increasing Preference for PCR Techniques
  • 4.4 Future Trends
    • 4.4.1 Innovations in Rapid Antigen Tests
  • 4.5 Impact Analysis

5. Rapid Test Kits Market - Europe Market Analysis

  • 5.1 Overview
  • 5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

6. Europe Rapid Test Kits Market Analysis - by Type

  • 6.1 Overview
  • 6.2 Rapid Antigen Testing
    • 6.2.1 Overview
    • 6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Rapid Antibody Testing
    • 6.3.1 Overview
    • 6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Rapid Test Kits Market Analysis - by Product

  • 7.1 Overview
  • 7.2 Over-the-Counter Rapid Testing Kit
    • 7.2.1 Overview
    • 7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Professional Rapid Testing Kit
    • 7.3.1 Overview
    • 7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Rapid Test Kits Market Analysis - by Technology

  • 8.1 Overview
  • 8.2 Lateral Flow Assay
    • 8.2.1 Overview
    • 8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Solid Phase
    • 8.3.1 Overview
    • 8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Agglutination
    • 8.4.1 Overview
    • 8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Immunospot Assay
    • 8.5.1 Overview
    • 8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cellular-Component Based
    • 8.6.1 Overview
    • 8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Rapid Test Kits Market Analysis - by Application

  • 9.1 Overview
  • 9.2 Blood Glucose Testing
    • 9.2.1 Overview
    • 9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Infectious Disease Testing
    • 9.3.1 Overview
    • 9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Cardiometabolic Testing
    • 9.4.1 Overview
    • 9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pregnancy and Fertility
    • 9.5.1 Overview
    • 9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Rapid Test Kits Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospital and Clinics
    • 10.2.1 Overview
    • 10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Home-Care
    • 10.4.1 Overview
    • 10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Rapid Test Kits Market - Country Analysis

  • 11.1 Europe
    • 11.1.1 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 Germany
        • 11.1.1.1.1 Overview
      • 11.1.1.2 Germany: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.1 Germany: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.2.2 Germany: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.2.3 Germany: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.2.4 Germany: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.2.4.1 Germany: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.2.5 Germany: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.3 United Kingdom
        • 11.1.1.3.1 Overview
      • 11.1.1.4 United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.4.2 United Kingdom: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.4.3 United Kingdom: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.4.4 United Kingdom: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.4.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.4.5 United Kingdom: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.5 France
        • 11.1.1.5.1 Overview
      • 11.1.1.6 France: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.6.1 France: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.6.2 France: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.6.3 France: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.6.4 France: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.6.4.1 France: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.6.5 France: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.7 Italy
        • 11.1.1.7.1 Overview
      • 11.1.1.8 Italy: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.8.1 Italy: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.8.2 Italy: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.8.3 Italy: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.8.4 Italy: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.8.4.1 Italy: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.8.5 Italy: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.9 Spain
        • 11.1.1.9.1 Overview
      • 11.1.1.10 Spain: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.10.1 Spain: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.10.2 Spain: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.10.3 Spain: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.10.4 Spain: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.10.4.1 Spain: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.10.5 Spain: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.11 Rest of Europe
        • 11.1.1.11.1 Overview
      • 11.1.1.12 Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.12.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.12.2 Rest of Europe: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.12.3 Rest of Europe: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.12.4 Rest of Europe: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.12.4.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.12.5 Rest of Europe: Rapid Test Kits Market Breakdown, by End User

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Rapid Test Kit Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 F. Hoffmann-La Roche Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Becton Dickinson and Co
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 ARKRAY Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Sysmex Partec GmbH
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Fujirebio Europe NV
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 bioMerieux SA
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Cepheid
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Meril Life Sciences Pvt Ltd
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 QIAGEN NV
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 OraSure Technologies Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Guangzhou Wondfo Biotech Co Ltd
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Denka Co Ltd
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Abbott Laboratories
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Trinity Biotech Plc
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Bio-Rad Laboratories Inc
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 Hologic Inc
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 DiaSorin SpA
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 Premier Medical Corp Pvt Ltd
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments
  • 13.19 Beckman Coulter Inc
    • 13.19.1 Key Facts
    • 13.19.2 Business Description
    • 13.19.3 Products and Services
    • 13.19.4 Financial Overview
    • 13.19.5 SWOT Analysis
    • 13.19.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners

List Of Tables

  • Table 1. Rapid Test Kits Market Segmentation
  • Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 4. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 5. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 6. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 7. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 8. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 9. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 10. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 11. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 12. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 13. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 14. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 15. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 16. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 17. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 18. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 19. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 20. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 21. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 22. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 23. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 24. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 25. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 26. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 27. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 28. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 29. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 30. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 31. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 32. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 33. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 34. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 35. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 36. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 37. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 38. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 39. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
  • Table 40. Recent Organic Growth Strategies in the Rapid Test Kit Market

List Of Figures

  • Figure 1. Rapid Test Kits Market Segmentation, By Country
  • Figure 2. Rapid Test Kits Market: Key Industry Dynamics
  • Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
  • Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
  • Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
  • Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
  • Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
  • Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 30. Europe: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 31. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 33. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 34. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Growth Strategies in the Rapid Test Kit Market